NCT05257148View on ClinicalTrials.gov

Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

May 26, 2021

Primary Completion Date

December 22, 2021

Study Completion Date

December 22, 2021

Conditions
Hypertension
Interventions
DRUG

Zofenopril 30 mg

Film-Coated tablets administered as one single dose to be taken in the morning (from 6 am to 10 am) with no restriction on food intake

DRUG

Nebivolol 5 mg

Tablet administered as one single dose to be taken in the morning (from 6 am to 10 am) with no restriction on food intake

DRUG

Zofenopril 30 mg + Nebivolol 5 mg

Both Film coated tablets of Zofenopril 30 mg and Nebivolol 5 mg Tablets will be taken in the morning (from 6 am to 10 am) with no restriction on food intake

Trial Locations (1)

20089

Istituto Clinico Humanitas, Milan

All Listed Sponsors
lead

Menarini International Operations Luxembourg SA

INDUSTRY